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THE COMBINED EFFECT OF STJLFANILAMIDE AND PENICILLIN
IN TREATMENT OF EXPERIMENTAL ERYSIPELOTHRIX
RHUSIOPATHIAE INFECTION OF MICE*
JOSEPH V. KLAUDER, M.D. AND ANNA M. RULE
In a previous communication (1) we reported the results of determinations oi
the therapeutic effect of sulfonamide compounds in mice inoculated with Er-
ysipelothrix rhusiopathiae. A report was also made of the ineffective use of
these compounds in treatment of patients with erysipeloid of Rosenbach and
in treatment of one patient with the septicemic form of the infection (2).
In our experimental study sulfanilamide, sulfapyridine, sulfathiazole and sul-
fadiazine were separately administered to mice orally in doses of 0.2 Gm. per
kilogram of body weight. To some the compounds were administered twice
daily for two days before inoculation with a virulent strain of Erysipelothrix rhu-
siopathiae and twice daily thereafter for six additional days. For others treat-
ment was begun four hours after inoculation and then administered twice daily
for six additional days; in still others, for eight additional days.
It was observed that 12.5 per cent of mice treated before or after the admin-
istration of these compounds survived. Additional evidence of some therapeutic
effect was the greater percentage (50 per cent) of survival of the animals treated
before inoculation and the longer time of survival of animals treated after inocu-
lation compared with those of the untreated control group. The therapeutic
effect of these compounds is therefore limited. Sulfanilamide and sulfapyridine
appeared to give better results than sulfathiazole and sulfadiazine. The thera-
peutic effect of these compounds was slightly enhanced when they were employed
in conjunction with subcurative injections of immune serum.
In another communication (3) we studied the therapeutic effects of penicillin
and streptomycin in mice inoculated with Erysipelothrix rhusiopathiae.
In this study (3) the sodium salt of penicillin was administered in 5 daily in-
jections for five successive days. The last of the daily injections (given in pea-
nut oil-beeswax was twice the amount of the preceding four. The number of
units per injection varied from 20 to 300. In some mice treatment was initiated
immediately after inoculation, for others eight hours after inoculation, for still
others sixteen hours after inoculation. The survival rate was 100 per cent with
600 units daily administered immediately after inoculation, and after treatment
with 1,800 units daily beginning 8 hours after inoculation. The survival rate
was 50 per cent after treatment with either 600 or 1200 units daily administered
in 8 hours after inoculation.
Streptomycin showed very slight therapeutic effect. Only four mice survived
of 48 treated with varying numbers of units up to 3,600 units daily.
The purpose of the present investigation was to determine if combined sul-
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fanilamide and penicillin exert a synergistic effect in treatment of experimental
Erysipelothrix rhusiopathiae infection of mice.
METHOD OF STUDY
A pure culture of Erysipelothrix rhusiopathiae maintained in lyophilic form
was employed. The organism was originally obtained from swine, the site of
"diamond" skin disease (a mild form of swine erysipelas (4)). Morphology and
virulence have remained unchanged. Sterile water was added to the lyophilic
TABLE I
Therapeutic effect of .sulfanilamide alone, of penicillin alone and of combined sulfanilamide
and penicillin in treatment of mice inoculated with Ery. rhusiopathiae'
NUMBER
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10
10
10
10
10
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MIDE (GM.
PER MOUSE)'
0.005
None
None
None
None
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100
200
300
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10
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2
9
10
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2
9
10
10
10
0
20
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100
100
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I By intra-abdominal injection of 0.2 cc. of 1:10,000 dilution of a 48-hour culture in
heart infusion broth.
'Orally (corresponding to 0.2 Gm. per kilogram of weight), 4 and 8 hours after inocula-
tion, thereafter at 9 a.m., 1 p.m., and 5 p.m., for nine successive days after inoculation.
'Sodium salt in aqueous solution injected intra-abdominally 4 and 8 hours after inocu-
ation, thereafter at 9 am., 1 p.m., and 5 p.m., for 9 successive days after inoculation.
culture and injected intra-abdominally into white mice. The heart blood of
moribund animals were cultured in heart infusion broth. It was observed that
0.2 cc. of a 1:10,000 dilution of a forty-eight hour culture killed mice in three
to four days. This amount injected intra-abdominally was used in the exper-
iments shown in table I.
A total of 120 Swiss mice with an average weight of about 25 Gm. were em-
ployed in the study. Ten mice constituting the control group were inoculated
with the same culture in the same dose as was employed for the treated animals.
Sulfanilamide was given orally in doses of 0.005 Gm. per mouse. Since the
average weight of the animals was about 25 Gm. this dose corresponded to about
0.2 Gm. per kilogram. Penicillin therapy comprised the sodium salt dissolved
in sterile water and was injected intra-abdominally.
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One group of mice was treated with 0.2 Gm. of sulfanilamide per kilogram.
Other groups were treated with varying amounts of penicillin with and without
conjoint administration of 0.5 Gm. of sulfanilamide. Treatment with sulfa-
nilamide was initiated 4 hours after inoculation and again in 4 hours. The day
following inoculation treatment was given at 9 a.m., 1 p.m., and 5 p.m. and re-
peated on this schedule for each of 9 days in succession, making a total of 10
days of treatment.
The heart blood of many moribund animals in the control group and in the
treated groups were cultured for demonstration of Erysipelothrix rhusiopathiae.
RESULTS
The results are shown in table I. Of ten mice treated only with sulfanilamide,
0.2 Gm. per kilogram of body weight, all succumbed on the fourth or fifth day
after inoculation. Of forty mice treated only with penicillin the results were as
follows: of ten mice treated with 50 units at each injection (total daily dose of
150 units) 40 per cent survived; of ten mice treated with 100 units at each injec-
tion 80 per cent survived. The survival rate was 100 per cent of the group of
ten mice treated with 200 units per injection and of another group of ten mice
treated with 300 units per injection.
Of seventy mice treated conjointly with sulfanilamide (0.2 Gm. per kilogram)
and penicillin, the results were as follows: Of ten mice treated with ten units of
penicillin at each injection all died in three to six days after inoculation. Of ten
mice treated with twenty-five units at each injection 20 per cent survived. Of
ten mice treated with fifty units at each injection 90 per cent survived. The
survival rate was 100 per cent of the group of ten mice receiving either 100 units,
200 units and 300 units at each injection.
A control group of ten mice died in three and four days after inoculation.
Moribund animals in the control group, as well as in the treated groups whose
heart blood was cultured, showed a pure growth of Erysipelothrix rhusiopathiae
COMMENT
As shown in table I, there is evidence of a synergistic action of sulfanilamide
and penicillin in treatment of the acute septicemic form of Erysipelothrix rhusio-
pathiae infection in mice.
None of the animals survived after treatment only with 0.2 Gm. of sulfanilamide
per kilogram. Forty per cent survived after treatment only with 50 units of
penicillin at each injection and 80 per cent after treatment only with 100 units of
penicillin at each injection. When sulfanilamide, 0.2 Gm. per kilogram, was given
conjointly with 25 units of penicillin at each injection, 20 per cent of the mice
survived and 90 per cent when 50 units of penicillin at each injection nas admin-
istered.
These results are consistent with the studies of others who have shown that
chemotherapeutic compounds have synergistic or additive effects against sensi-
tive organisms both in vitro and in vivo. Such studies have been reviewed by
Kolmer (5a, b). Combined sulfanilamide and penicillin have been reported to
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exert a synergistic effect in vitro against staphylococci, streptococci and gonococci,
and also brucella and other gram negative organisms, particularly with minimal
effective concentration of each. In experimental animal infections, such effect has
been reported with penicillin-sulfanilamide therapy in pneumococci, streptococci
and other infections, and with penicillin plus mapharsen and bismuth in syphilis.
Synergistic effects have also been observed with combined streptomycin-
sulfanilamide compounds against various enteric gram-negative bacilli, and with
streptomycin-promin compounds in the treatment of experimental tuberculosis.
Clinically, combined penicillin-sulfanilamide therapy has been reported to be
more effective than either agent alone in the treatment of pneumococci pneumonia,
putrid lung abscess, pneumococcic and staphylococcic meningitis, and in the pre-
vention of infection following surgery.
There is no report in the literature of experimental or clinical studies of syner-
gistic action of sulfonamide compounds and penicillin in treatment of Erysipelo-
thrix rhusiopathiae infection. Evidence of action as reported in this study
enhances therapeusis of infection in man.
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